Quince seed mucilage/β-cyclodextrin/Mmt-Na+-co-poly (methacrylate) based pH-sensitive polymeric carriers for controlled delivery of Capecitabine
Copyright © 2023. Published by Elsevier B.V..
In current work, quince seed mucilage and β-Cyclodextrin based pH regulated hydrogels were developed using aqueous free radical polymerization to sustain Capecitabine release patterns and to overcome its drawbacks, such as high dose frequency, short half-life, and low bioavailability. Developed networks were subjected to thermal analysis, Fourier transforms infrared spectroscopy, powder x-ray diffraction, elemental analysis, scanning electron microscopy, equilibrium swelling, and in-vitro release investigations to assess the network system's stability, complexation, morphology, and pH responsiveness. Thermally stable pH-responsive cross-linked networks were formed. Nanocomposite hydrogels were prepared by incorporating Capecitabine-containing clay into the swollen hydrogels. All the formulations exhibited equilibrium swelling ranging from 67.98 % to 92.98 % at pH 7.4. Optimum Capecitabine loading (88.17 %) was noted in the case of hydrogels, while it was 74.27 % in nanocomposite hydrogels. Excellent gel content (65.88 %-93.56 %) was noticed among developed formulations. Elemental analysis ensured the successful incorporation of Capecitabine. Nanocomposite hydrogels released 80.02 % longer than hydrogels after 30 h. NC hydrogels had higher t1/2 (10.57 h), AUC (121.52 μg.h/ml), and MRT (18.95 h) than hydrogels in oral pharmacokinetics. These findings imply that the pH-responsive carrier system may improve Capecitabine efficacy and reduce dosing frequency in cancer therapy. Toxicity profiling proved the system's safety, non-toxicity, and biocompatibility.
Medienart: |
E-Artikel |
---|
Erscheinungsjahr: |
2023 |
---|---|
Erschienen: |
2023 |
Enthalten in: |
Zur Gesamtaufnahme - volume:253 |
---|---|
Enthalten in: |
International journal of biological macromolecules - 253(2023), Pt 4 vom: 31. Dez., Seite 127032 |
Sprache: |
Englisch |
---|
Beteiligte Personen: |
Yasmin, Tahira [VerfasserIn] |
---|
Links: |
---|
Anmerkungen: |
Date Completed 29.11.2023 Date Revised 29.11.2023 published: Print-Electronic Citation Status MEDLINE |
---|
doi: |
10.1016/j.ijbiomac.2023.127032 |
---|
funding: |
|
---|---|
Förderinstitution / Projekttitel: |
|
PPN (Katalog-ID): |
NLM362393729 |
---|
LEADER | 01000naa a22002652 4500 | ||
---|---|---|---|
001 | NLM362393729 | ||
003 | DE-627 | ||
005 | 20231226091139.0 | ||
007 | cr uuu---uuuuu | ||
008 | 231226s2023 xx |||||o 00| ||eng c | ||
024 | 7 | |a 10.1016/j.ijbiomac.2023.127032 |2 doi | |
028 | 5 | 2 | |a pubmed24n1207.xml |
035 | |a (DE-627)NLM362393729 | ||
035 | |a (NLM)37742901 | ||
035 | |a (PII)S0141-8130(23)03929-6 | ||
040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
041 | |a eng | ||
100 | 1 | |a Yasmin, Tahira |e verfasserin |4 aut | |
245 | 1 | 0 | |a Quince seed mucilage/β-cyclodextrin/Mmt-Na+-co-poly (methacrylate) based pH-sensitive polymeric carriers for controlled delivery of Capecitabine |
264 | 1 | |c 2023 | |
336 | |a Text |b txt |2 rdacontent | ||
337 | |a ƒaComputermedien |b c |2 rdamedia | ||
338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
500 | |a Date Completed 29.11.2023 | ||
500 | |a Date Revised 29.11.2023 | ||
500 | |a published: Print-Electronic | ||
500 | |a Citation Status MEDLINE | ||
520 | |a Copyright © 2023. Published by Elsevier B.V. | ||
520 | |a In current work, quince seed mucilage and β-Cyclodextrin based pH regulated hydrogels were developed using aqueous free radical polymerization to sustain Capecitabine release patterns and to overcome its drawbacks, such as high dose frequency, short half-life, and low bioavailability. Developed networks were subjected to thermal analysis, Fourier transforms infrared spectroscopy, powder x-ray diffraction, elemental analysis, scanning electron microscopy, equilibrium swelling, and in-vitro release investigations to assess the network system's stability, complexation, morphology, and pH responsiveness. Thermally stable pH-responsive cross-linked networks were formed. Nanocomposite hydrogels were prepared by incorporating Capecitabine-containing clay into the swollen hydrogels. All the formulations exhibited equilibrium swelling ranging from 67.98 % to 92.98 % at pH 7.4. Optimum Capecitabine loading (88.17 %) was noted in the case of hydrogels, while it was 74.27 % in nanocomposite hydrogels. Excellent gel content (65.88 %-93.56 %) was noticed among developed formulations. Elemental analysis ensured the successful incorporation of Capecitabine. Nanocomposite hydrogels released 80.02 % longer than hydrogels after 30 h. NC hydrogels had higher t1/2 (10.57 h), AUC (121.52 μg.h/ml), and MRT (18.95 h) than hydrogels in oral pharmacokinetics. These findings imply that the pH-responsive carrier system may improve Capecitabine efficacy and reduce dosing frequency in cancer therapy. Toxicity profiling proved the system's safety, non-toxicity, and biocompatibility | ||
650 | 4 | |a Journal Article | |
650 | 4 | |a Capecitabine | |
650 | 4 | |a Montmorillonite sodium | |
650 | 4 | |a Nanocomposite | |
650 | 4 | |a Pharmacokinetic evaluation | |
650 | 4 | |a Quince seed mucilage | |
650 | 4 | |a β-CD | |
650 | 7 | |a Methacrylates |2 NLM | |
650 | 7 | |a Capecitabine |2 NLM | |
650 | 7 | |a 6804DJ8Z9U |2 NLM | |
650 | 7 | |a Nanogels |2 NLM | |
650 | 7 | |a Polymers |2 NLM | |
650 | 7 | |a Polysaccharides |2 NLM | |
650 | 7 | |a Hydrogels |2 NLM | |
650 | 7 | |a beta-Cyclodextrins |2 NLM | |
700 | 1 | |a Mahmood, Asif |e verfasserin |4 aut | |
700 | 1 | |a Farooq, Muhammad |e verfasserin |4 aut | |
700 | 1 | |a Rehman, Umaira |e verfasserin |4 aut | |
700 | 1 | |a Sarfraz, Rai Muhammad |e verfasserin |4 aut | |
700 | 1 | |a Ijaz, Hira |e verfasserin |4 aut | |
700 | 1 | |a Akram, Muhammad Rouf |e verfasserin |4 aut | |
700 | 1 | |a Boublia, Abir |e verfasserin |4 aut | |
700 | 1 | |a Salem Bekhit, Mounir M |e verfasserin |4 aut | |
700 | 1 | |a Ernst, Barbara |e verfasserin |4 aut | |
700 | 1 | |a Benguerba, Yacine |e verfasserin |4 aut | |
773 | 0 | 8 | |i Enthalten in |t International journal of biological macromolecules |d 1992 |g 253(2023), Pt 4 vom: 31. Dez., Seite 127032 |w (DE-627)NLM012627356 |x 1879-0003 |7 nnns |
773 | 1 | 8 | |g volume:253 |g year:2023 |g number:Pt 4 |g day:31 |g month:12 |g pages:127032 |
856 | 4 | 0 | |u http://dx.doi.org/10.1016/j.ijbiomac.2023.127032 |3 Volltext |
912 | |a GBV_USEFLAG_A | ||
912 | |a GBV_NLM | ||
951 | |a AR | ||
952 | |d 253 |j 2023 |e Pt 4 |b 31 |c 12 |h 127032 |